- APP-CHMINACA
- PX-3
- WO 2009/106980 #14
- Nα-[1-(Cyclohexylmethyl)-1H-indazole-3-carbonyl]-L-phenylalaninamide
- N-[(2S)-1-Amino-1-oxo-3-phenylpropan-2-yl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide
Doi, T; Tagami, T; Takeda, A; Asada, A; Sawabe, Y. Evaluation of carboxamide-type synthetic cannabinoids as CB1/CB2 receptor agonists: difference between the enantiomers Forensic Toxicol., 1 Jan 2018, 36 (1), 51-60. 698 kB. https://doi.org/10.1007/s11419-017-0378-5 #16 NMR
EMCDDA. New drugs in Europe, 2015, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2016. 1.0 MB. #32
Hess, C; Murach, J; Krueger, L; Scharrenbroch, L; Unger, M; Madea, B; Sydow, K. Simultaneous detection of 93 synthetic cannabinoids by liquid chromatography-tandem mass spectrometry and retrospective application to real forensic samples Drug Test. Anal., 1 May 2017, 9 (5), 721-733. 267 kB. https://doi.org/10.1002/dta.2030 #APP CHMINACA LC,MS
Abbate, V; Schwenk, M; Presley, BC; Uchiyama, N. The ongoing challenge of novel psychoactive drugs of abuse. Part I. Synthetic cannabinoids (IUPAC Technical Report) Pure Appl. Chem., 28 Aug 2018, 90 (8), 1255–1282. 1.0 MB. https://doi.org/10.1515/pac-2017-0605 #8. PX-3
Vicente, JL; Chassaigne, H; Holland, MV; Reniero, F; Kolář, K; Tirendi, S; Vandecasteele, I; Vinckier, I; Guillou, C. Systematic analytical characterization of new psychoactive substances: A case study Forensic Sci. Int., 1 Aug 2016, 265, 107–115. 2.5 MB. https://doi.org/10.1016/j.forsciint.2016.01.024 #5F-AMB MS,NMR,IR,other
Banister, SD; Connor, M. The chemistry and pharmacology of synthetic cannabinoid receptor agonist new psychoactive substances: Evolution In New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology; Maurer, HH; Brandt, SD, Eds., Springer, Berlin, Heidelberg, 1 Jan 2018; pp 191-226. 1.2 MB. https://doi.org/10.1007/164_2018_144 #47